Pneumonia
TDB Supports Aodh Lifesciences in Pneumonia Treatment Innovation
The Technology Development Board (TDB) of India has backed Aodh Lifesciences Pvt. Ltd. in developing an Indigenous Antibiotic Nebulization Suspension (AONEUM-04) aimed at treating pneumonia and combating antimicrobial resistance. This innovative technology allows for localized antibiotic delivery through nebulization, enhancing treatment efficacy while minimizing side effects. The project aligns with